Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Petr Jarolim

Showing results (131-140 of 187) with videos related to

Pageof 19
Sort By:
Circulation|May 14, 2003
Elevated plasma levels of the atherogenic mediator soluble CD40 ligand in diabetic patients: a novel target of thiazolidinedionesNerea Varo, David Vicent, Peter Libby, et al.
Circulation. Heart Failure|January 21, 2020
Mechanistic Effects of Spironolactone on Cardiovascular and Renal Biomarkers in Heart Failure With Preserved Ejection Fraction: A TOPCAT Biorepository StudyPeder L Myhre, Muthiah Vaduganathan, Eileen O'Meara, et al.
Clinical Cardiology|August 15, 2017
Study of young patients with myocardial infarction: Design and rationale of the YOUNG-MI RegistryAvinainder Singh, Bradley Collins, Arman Qamar, et al.
JCI Insight|July 8, 2021
ACTH treatment promotes murine cardiac allograft acceptanceJing Zhao, Liwei Jiang, Mayuko Uehara, et al.
Journal of the American College of Cardiology|April 15, 2014
Fibroblast growth factor-23, cardiovascular prognosis, and benefit of angiotensin-converting enzyme inhibition in stable ischemic heart diseaseJacob A Udell, David A Morrow, Petr Jarolim, et al.
Scientific Reports|July 25, 2019
Increased lymphocyte activation and atherosclerosis in CD47-deficient miceDaniel Engelbertsen, Anu Autio, Robin A F Verwilligen, et al.
European Heart Journal|March 24, 2021
Serial assessment of biomarkers and the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trialKazuma Oyama, Robert P Giugliano, David D Berg, et al.
The New England Journal of Medicine|September 8, 2010
Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathyCarolyn Y Ho, Begoña López, Otavio R Coelho-Filho, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 9, 2011
Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKDAkshay S Desai, Robert Toto, Petr Jarolim, et al.
The Lancet. Infectious Diseases|January 14, 2023
Tracking immune correlates of protection for emerging SARS-CoV-2 variantsEric J Nilles, Cecilia Then Paulino, Michael de St Aubin, et al.
Pageof 19

Showing results (131-140 of 187) with videos related to

Sort By:
Pageof 19
Circulation|May 14, 2003
Elevated plasma levels of the atherogenic mediator soluble CD40 ligand in diabetic patients: a novel target of thiazolidinedionesNerea Varo, David Vicent, Peter Libby, et al.
Circulation. Heart Failure|January 21, 2020
Mechanistic Effects of Spironolactone on Cardiovascular and Renal Biomarkers in Heart Failure With Preserved Ejection Fraction: A TOPCAT Biorepository StudyPeder L Myhre, Muthiah Vaduganathan, Eileen O'Meara, et al.
Clinical Cardiology|August 15, 2017
Study of young patients with myocardial infarction: Design and rationale of the YOUNG-MI RegistryAvinainder Singh, Bradley Collins, Arman Qamar, et al.
JCI Insight|July 8, 2021
ACTH treatment promotes murine cardiac allograft acceptanceJing Zhao, Liwei Jiang, Mayuko Uehara, et al.
Journal of the American College of Cardiology|April 15, 2014
Fibroblast growth factor-23, cardiovascular prognosis, and benefit of angiotensin-converting enzyme inhibition in stable ischemic heart diseaseJacob A Udell, David A Morrow, Petr Jarolim, et al.
Scientific Reports|July 25, 2019
Increased lymphocyte activation and atherosclerosis in CD47-deficient miceDaniel Engelbertsen, Anu Autio, Robin A F Verwilligen, et al.
European Heart Journal|March 24, 2021
Serial assessment of biomarkers and the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trialKazuma Oyama, Robert P Giugliano, David D Berg, et al.
The New England Journal of Medicine|September 8, 2010
Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathyCarolyn Y Ho, Begoña López, Otavio R Coelho-Filho, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 9, 2011
Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKDAkshay S Desai, Robert Toto, Petr Jarolim, et al.
The Lancet. Infectious Diseases|January 14, 2023
Tracking immune correlates of protection for emerging SARS-CoV-2 variantsEric J Nilles, Cecilia Then Paulino, Michael de St Aubin, et al.
Pageof 19